Hypertonic sodium lactate infusion reduces vasopressor requirements and biomarkers of brain and cardiac injury after experimental cardiac arrest

Filippo Annoni,Fuhong Su,Lorenzo Peluso,Ilaria Lisi,Enrico Caruso,Francesca Pischiutta,Elisa Gouvea Bogossian,Bruno Garcia,Hassane Njimi,Jean-Louis Vincent,Nicolas Gaspard,Lorenzo Ferlini,Jacques Creteur,Elisa R. Zanier,Fabio Silvio Taccone
DOI: https://doi.org/10.1186/s13054-023-04454-1
IF: 15.1
2023-04-25
Critical Care
Abstract:Prognosis after resuscitation from cardiac arrest (CA) remains poor, with high morbidity and mortality as a result of extensive cardiac and brain injury and lack of effective treatments. Hypertonic sodium lactate (HSL) may be beneficial after CA by buffering severe metabolic acidosis, increasing brain perfusion and cardiac performance, reducing cerebral swelling, and serving as an alternative energetic cellular substrate. The aim of this study was to test the effects of HSL infusion on brain and cardiac injury in an experimental model of CA.
critical care medicine
What problem does this paper attempt to address?